Something is changing in adherence to CPAP therapy: real world data after 1 year of treatment in patients with obstructive sleep apnea

Obstructive sleep apnea syndrome (OSA) is a common sleep disorder, affecting at least 24% of male and 9% of female population [1]. Despite progresses in alternative treatment options, continuous positive airway pressure (CPAP) therapy is still the first-line treatment in moderate to severe OSA. The effectiveness of CPAP treatment is proportional to the usage: the greater the number of hours of CPAP use per night the greater the improvement in OSA symptoms, daytime sleepiness, quality of life, sleep architecture and blood pressure. Adherence to treatment, however, is the crucial issue: in many case series more than 50% of patients with OSA had interrupted treatment 1 year after the prescription [2]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of interest: Elisa Morrone Conflict of interest: Dr. GIORDANO has nothing to disclose. Conflict of interest: Sonia Carli Conflict of interest: Dina Visca Conflict of interest: Fabio Rossato Conflict of interest: Massimo Godio Conflict of interest: Elena Paracchini Conflict of interest: Sabrina Rossi Conflict of interest: Bruno Balbi Conflict of interest: Carlo Sacco Conflict of interest: Alberto Braghiroli